Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2014
08/21/2014WO2014127276A1 Ovarian cancer vaccines and vaccination methods
08/21/2014WO2014127149A1 Substituted 4,5-dihydropyrazole-1,2,4-oxadiazole derivatives as sphingosine receptor modulators
08/21/2014WO2014127141A1 Substituted 1h-pyrazol-1,2,4-oxadiazole derivatives as sphingosine receptor modulators
08/21/2014WO2014127006A1 Composition and method for diagnosis and immunotherapy of lung cancer
08/21/2014WO2014126836A1 Tubulysin compounds, methods of making and use
08/21/2014WO2014125273A1 Therapeutic and diagnostic target for cancer comprising dll3 binding reagents
08/21/2014WO2014125041A1 Treatment of peripheral t cell lymphoma
08/21/2014WO2014100620A3 Compounds and methods for kinase modulation, and indications therefor
08/21/2014WO2014096388A3 Novel benzimidazole derivatives as kinase inhibitors
08/21/2014WO2014083567A8 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
08/21/2014WO2014062659A4 Methods of treating ocular diseases
08/21/2014US20140235924 Method of radiotherapy
08/21/2014US20140235844 Short Interfering RNA (siRNA) Analogues
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140234362 Defensin-antigen fusion proteins
08/21/2014US20140234334 Peptides and related molecules that bind to tall-1
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767541A1 LPA receptor agonists and antagonists
08/20/2014EP2767538A1 Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/20/2014EP2767273A1 Death-associated protein kinases, inhibitors and activators thereof for use in pharmaceutical compositions and in predictive medicine
08/20/2014EP2766364A1 Folate conjugates of albumin-binding entities
08/20/2014EP2766363A1 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions containing them
08/20/2014EP2766361A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
08/20/2014EP2766356A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
08/20/2014EP2766355A2 Pyrazol-3-ones that activate pro-apoptotic bax
08/20/2014EP2766354A1 Protein kinase inhibitors
08/20/2014EP2766352A1 Indazole compounds as kinase inhibitors and method of treating cancer with same
08/20/2014EP2766048A1 Pyrrolobenzodiazepines and conjugates thereof
08/20/2014EP2766045A2 Treatment of breast cancer with companion diagnostic
08/20/2014EP2766035A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
08/20/2014EP2766012A2 Compositions useful in treating nephropathy and methods for preparation of same
08/20/2014EP2765990A2 Solid dispersion
08/19/2014US8809542 Salts of benzimidazole compound and use thereof
08/19/2014US8809362 Anticancer agent sensitivity-determining marker
08/19/2014US8809349 Processes for preparing isoquinolinones and solid forms of isoquinolinones
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809321 Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809280 Therapeutic peptides
08/19/2014US8809011 HIFα hydroxylation assay
08/19/2014US8808742 Compositions and methods for preparing and using same
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014CA2795275C Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
08/19/2014CA2675231C A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof
08/19/2014CA2675142C Fused aromatic difluoromethanephosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
08/19/2014CA2649924C Inhibitors of c-fms kinase
08/19/2014CA2647445C N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
08/19/2014CA2627839C Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
08/19/2014CA2490659C Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2411596C Therapeutic agents - ii
08/19/2014CA2375106C Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
08/19/2014CA2364492C Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
08/14/2014WO2014124418A1 Modulators of methyl modifying enzymes, compositions and uses thereof
08/14/2014WO2014124245A1 Modified glycolipids and methods of making and using the same
08/14/2014WO2014123977A1 Geranylgeranylacetone formulations
08/14/2014WO2014123900A1 Anti-cancer and anti-hiv compounds
08/14/2014WO2014123612A1 Methods of treating melanoma
08/14/2014WO2014123590A1 A composition with extracts from olive leaf, yarrow and rosemary for treating human diseases and conditions
08/14/2014WO2014123476A1 Improved treatment for adenoid cystic carcinoma
08/14/2014WO2014123418A1 Groundbreaking platform technology for specific binding to necrotic cells
08/14/2014WO2014123406A1 A composition for treating leukemia
08/14/2014WO2014123332A1 7h-pyrrolo[2,3-d]pyrimidine-4-thiol derivative useful as jak-3 inhibitor
08/14/2014WO2014122222A1 Hydroxamate derivatives bearing amide-lactams as potent hdac inhibitors and their uses as medicaments
08/14/2014WO2014121901A1 Polymorphic forms
08/14/2014WO2014101295A3 Isoxazole derivative that inhibits activity of janus kinases (jaks)
08/14/2014WO2014100719A3 Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof
08/14/2014WO2014100143A3 Liquid antibody formulation with improved aggregation properties
08/14/2014WO2014090396A3 Use of maleimide derivatives for preventing and treating cancer
08/14/2014WO2014086480A8 Lignan compositions
08/14/2014WO2014066848A9 Super-enhancers and methods of use thereof
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227194 Preparation for Restenosis Prevention
08/14/2014US20140227193 Preparation for Restenosis Prevention
08/14/2014US20140227192 Preparation for Restenosis Prevention
08/14/2014US20140227177 Scanning Suspension Comprising a Particle with a Diameter of at least 1 Micrometer
08/13/2014EP2765133A1 Acylated derivative of homoharringtonine, preparation method therefor, and application thereof
08/13/2014EP2764873A1 Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound
08/13/2014EP2764866A1 Inhibitors of nedd8-activating enzyme
08/13/2014EP2764865A2 Cancer treatment
08/13/2014EP2764026A2 Antibody specifically binding to epitope in sema domain of c-met
08/13/2014EP2764025A1 Ige anti -hmw-maa antibody
08/13/2014EP2764024A1 Anti c-met antibody and uses thereof
08/13/2014EP2764023A2 Anti-human sema4a antibodies useful to treat disease
08/13/2014EP2763998A1 Tri-heterocyclic derivatives, preparation process and uses thereof
08/13/2014EP2763994A2 Novel quinoxaline inhibitors of pi3k
08/13/2014EP2763982A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
08/13/2014EP2763972A1 New apoptosis inducing compounds
08/13/2014EP2763962A1 Methods of treatment using modulators of sirt2
08/13/2014EP2763690A1 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system
08/13/2014EP2650367A9 Human monoclonal antibody
08/13/2014CN103987730A 特异性结合c-met的sema域中表位的抗体 Specifically binds to c-met sema domain epitope
08/13/2014CN103987729A 癌胚抗原相关细胞粘附分子(ceacam)的抗体 Carcinoembryonic antigen-related cell adhesion molecule (ceacam) antibody
08/13/2014CN103987728A 抗癌融合蛋白 Anticancer fusion protein
08/13/2014CN103987718A 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓 As a non-symmetric dimers pbd compounds for inclusion in the targeting conjugate pyrrolo benzodiazepine
08/13/2014CN103987711A 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物 As 8-Carbamoyl for treating cancer and autoimmune diseases, and immune inducing agent apoptosis-2- (2,3-di-substituted pyridin-6-yl) -1,2,3,4- Hydrogen isoquinoline derivatives
08/13/2014CN103987709A 用于制备可用作atr激酶抑制剂的化合物的方法 The method of preparing compounds useful as kinase inhibitors for use atr
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 2211